International Union Against Tuberculosis and Lung Disease

Recent papers from International Union Against Tuberculosis and Lung Disease

1. Evaluation of an “upfront molecular testing” strategy under the National Tuberculosis Elimination Programme (NTEP) in Thiruvananthapuram, Kerala, IndiaClinical Epidemiology and Global Health · 2026
2. Prioritizing research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimensEuropean Respiratory Journal · 2026
3. Lessons learned from implementing a large-scale contact investigation and TB preventive treatment project in IndiaIJTLD OPEN · 2026
4. Causes of Death among People Affected by Tuberculosis: A Cross-Sectional Study from Trivandrum, Kerala, IndiaIndian Journal of Community Medicine · 2026
5. End-user global study to identify countries’ challenges and solutions in the uptake and implementation of new tuberculosis treatment regimensEuropean Respiratory Journal · 2026
6. Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocolIJTLD OPEN · 2026
7. Developing, Implementing, and Evaluating a Competency-Based Nursing Education Curriculum among Nurse Educators of Odisha—Using Kern’s Approach and Kirkpatrick Training Evaluation ModelIndian Journal of Community Medicine · 2026
8. Infection prevention and control of Candida auris in pediatric settingsAntimicrobial Stewardship & Healthcare Epidemiology · 2026
9. Tuberculosis Preventive Treatment in People Living with HIV in Uganda: Facilitators and Barriers for Initiation and CompletionTropical Medicine and Infectious Disease · 2025
10. Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countriesVaccine · 2025
11. Clinical best practices for caring for people with expanded resistance to newer TB drugsIJTLD OPEN · 2025
12. Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of LinezolidJournal of Infection · 2025
13. Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in researchPLOS Global Public Health · 2025
14. Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldThe Lancet Microbe · 2025
15. Evaluation of person-centred outcome measures for use in clinical trials of tuberculosis therapeutics2025
16. Pharmacogenomic heterogeneity of N-acetyltransferase 2 : a comprehensive analysis of real world data in Indian tuberculosis patients and from literature and database reviewAnnals of Medicine · 2025
17. 24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationThe Lancet Global Health · 2025
18. Comparing cost-effectiveness of short-course regimens for drug-resistant tuberculosis treatment in IndiaInternational Journal of Technology Assessment in Health Care · 2025
19. The Cost-Effectiveness of Group B Streptococcus Screening Strategies in Pregnant Women for the Prevention of Newborn Early-onset Group B Streptococcus : A Systematic Review2024
20. The potential distraction of a pan-regimen approach to tuberculosisThe Lancet Global Health · 2024